Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore

Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore

10.1080/14737167.2023.2295474

Saved in:
Bibliographic Details
Main Authors: Elaine Hsuen Lim, Andrew Lim, Jasmeet Singh Khara, John Cheong, Jek Fong, Sivabalan Sivanesan, Matt Griffiths, Emma New, Soo-chin Lee
Other Authors: MEDICINE
Format: Article
Published: Taylor & Francis 2024
Online Access:https://scholarbank.nus.edu.sg/handle/10635/247511
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Description
Summary:10.1080/14737167.2023.2295474

Similar Items